ObjectivesTo investigate predictive factors for good outcome of ultrasound intra-articular glucocorticoids in knee osteoarthritis (OA).MethodsWe conducted a prospective monocenter cohort study including 116 patients with knee OA, after failure to standard treatments, with pain >4 (numerical rating scale NRS 0–10). Patients received an ultrasound-guided injection of 40 mg triamcinolone acetonide in their most painful knee. We exhaustively collected demographic and clinical data at inclusion, as well as lab, radiographs and ultrasound parameters of the included knees. WOMAC score was calculated at inclusion and after 4 weeks. Responders were defined as patients with at least 40% improvement of their WOMAC score. Univariate analysis was performed in order to select possible predictive factors, and stepwise multiple logistic regression analyses were conducted to identify predictors of response.ResultsAmong the 116 patients, 101 were females. Median age was 64 years (40–85) and mean duration of the disease was 14.1±14,8 years. Mean BMI was 29.9±3.8 Kg/m2. Mean NRS of pain was 8.4±1.2 and mean WOMAC was 73.3±11,8 at inclusion. 70.0% of the knees were grade 3 or 4 of Kellgren-Lawrence. 98% of knees expressed ultrasound synovial effusion and/or hypertrophy at inclusion. After 4 weeks, 61.2% of patients were responders. Regression analysis showed that patients with a BMI <30 Kg/m2 (OR=0.38, 95% CI 0.16–0.89) and an ESR <20 mm (OR=0.27, 95% CI 0.08–0.90) were more likely to respond to ultrasound-guided glucocorticoids injection. Having both predictive factors of good response increases the response rate to 73.5%, whereas having no predictive factor decreases the response rate to 25.0%.ConclusionsOur study is the largest study evaluating predictive factors of response for intra-articular glucocorticoids injections in knee OA. Also, it is the first study of predictive factors for ultrasound-guided injections. Patients with high BMIs and high ESR seem less likely to respond to intra-articular injections.Disclosure of InterestNone declared
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.